← All companies

TRDA

Entrada Therapeutics, Inc.

TRDA Nasdaq Pharmaceutical Preparations EDGAR ↗

$7.26

+0.49 +7.24%

Key statistics

from XBRL data in SEC filings

Market cap

$282M

Revenue (TTM)

$5.74M

Net income (TTM)

-$166M

EPS (TTM)

$-4.00

P/E ratio

—

Dividend yield

—

Free cash flow

-$130M

Cash

$76.4M

Total assets

$336M

Gross margin

—

52-week range

$4.93 – $16.45

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 10, 2026 8-K Regulation FD disclosure May 19, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 11, 2025 8-K Director or officer change; Regulation FD disclosure Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Exit or disposal costs Apr 29, 2025 8-K Regulation FD disclosure; Other events Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Regulation FD disclosure; Other events Feb 24, 2025 8-K Regulation FD disclosure; Other events Feb 3, 2025 8-K Results of operations (earnings release); Other events Jan 15, 2025 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement; Other events Jun 24, 2024 8-K Regulation FD disclosure; Other events Jun 24, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Director or officer change Jan 3, 2024 8-K Director or officer change Dec 6, 2023 8-K Regulation FD disclosure; Other events Nov 22, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 8-K Entered a material agreement; Other events Nov 1, 2023 8-K Entered a material agreement Sep 29, 2023